CRVO 8-K 2026-09-28
CervoMed Inc. (CRVO) 8-K dated 2026-09-28 — accession 0001437749-26-031389.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
CervoMed Inc. filed a 8-K on 2026-09-28. Accession 0001437749-26-031389.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CRVO revenue for 2025-12-31 was $4.0M. Net income was -$27.0M. Revenue was down 58.9% from 2024-12-31 to 2025-12-31. CRVO currently screens at market cap $28.8M.
Not investment advice. The CRVO SEC hub lists recent forms. The stock page is the research view.